DK173536B1 - cDNA-sekvens, som koder for modent humant vævsfaktorinhibitor-protein - Google Patents

cDNA-sekvens, som koder for modent humant vævsfaktorinhibitor-protein Download PDF

Info

Publication number
DK173536B1
DK173536B1 DK198804134A DK413488A DK173536B1 DK 173536 B1 DK173536 B1 DK 173536B1 DK 198804134 A DK198804134 A DK 198804134A DK 413488 A DK413488 A DK 413488A DK 173536 B1 DK173536 B1 DK 173536B1
Authority
DK
Denmark
Prior art keywords
tfi
sequence
cdna
protein
tissue factor
Prior art date
Application number
DK198804134A
Other languages
Danish (da)
English (en)
Other versions
DK413488A (da
DK413488D0 (da
Inventor
Kuniko Kusano Kretzmer
Tze-Chein Wun
John Broze George Jr
Original Assignee
Univ Washington
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22410671&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK173536(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/123,753 external-priority patent/US4966852A/en
Application filed by Univ Washington, Monsanto Co filed Critical Univ Washington
Publication of DK413488D0 publication Critical patent/DK413488D0/da
Publication of DK413488A publication Critical patent/DK413488A/da
Priority to DK200001612A priority Critical patent/DK174754B1/da
Application granted granted Critical
Publication of DK173536B1 publication Critical patent/DK173536B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK198804134A 1987-11-23 1988-07-22 cDNA-sekvens, som koder for modent humant vævsfaktorinhibitor-protein DK173536B1 (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK200001612A DK174754B1 (da) 1987-11-23 2000-10-27 Humane vævsfaktorinhibitor (TFI), antistof med bindingsspecificitet herfor, fremgangsmåde til anvendelse af en TFI-peptid-kolonne til at oprense et antistof og fremgangsmåder til detektion af TFI eller et polypeptid omfattende....

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/123,753 US4966852A (en) 1987-07-23 1987-11-23 DNA clone of human tissue factor inhibitor
US12375387 1987-11-23

Publications (3)

Publication Number Publication Date
DK413488D0 DK413488D0 (da) 1988-07-22
DK413488A DK413488A (da) 1989-05-24
DK173536B1 true DK173536B1 (da) 2001-02-05

Family

ID=22410671

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198804134A DK173536B1 (da) 1987-11-23 1988-07-22 cDNA-sekvens, som koder for modent humant vævsfaktorinhibitor-protein

Country Status (15)

Country Link
EP (1) EP0318451B1 (no)
JP (5) JP2836823B2 (no)
KR (1) KR930000274B1 (no)
AT (1) ATE111518T1 (no)
AU (1) AU604139B2 (no)
CA (1) CA1341223C (no)
DE (1) DE3851511T2 (no)
DK (1) DK173536B1 (no)
ES (1) ES2063769T3 (no)
FI (1) FI93365C (no)
IE (1) IE65393B1 (no)
IL (1) IL87171A (no)
NO (2) NO310466B1 (no)
NZ (1) NZ225535A (no)
PT (1) PT88076B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner
US5378614A (en) * 1989-08-18 1995-01-03 Novo Nordisk A/S Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast
DK0439442T3 (da) * 1990-01-25 1996-07-08 Univ Washington Faktor X-LACI-hybridprotein
IE913004A1 (en) * 1990-08-27 1992-03-11 Monsanto Co Anticoagulant combination of laci and sulfated¹polysaccharides
DK261490D0 (da) * 1990-10-31 1990-10-31 Novo Nordisk As New pharmaceutical compound
US5346991A (en) * 1991-06-13 1994-09-13 Genentech, Inc. Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US5455338A (en) * 1993-11-05 1995-10-03 Zymogenetics, Inc. DNA encoding novel human kunitz-type inhibitors and methods relating thereto
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
PL374506A1 (en) 2001-10-15 2005-10-31 Chiron Corporation Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi)
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
US7064107B2 (en) 2002-06-07 2006-06-20 Dyax Corp. Prevention and reduction of blood loss
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
CA2635589C (en) 2005-12-29 2017-01-17 Dyax Corp. Protease inhibition
CA2747721C (en) 2008-12-19 2021-07-20 Baxter International Inc. Tfpi inhibitors and methods of use
JP2013516389A (ja) 2009-01-06 2013-05-13 ダイアックス コーポレーション カリクレイン阻害剤による粘膜炎治療
CA3021759A1 (en) 2010-01-06 2011-07-14 Dyax Corp. Plasma kallikrein binding proteins
CN103025345B (zh) 2010-03-19 2016-01-20 巴克斯特国际公司 Tfpi抑制剂及使用方法
AU2012204202A1 (en) 2011-01-06 2013-07-11 Dyax Corp. Plasma kallikrein binding proteins
BR112013032235A2 (pt) 2011-06-15 2016-11-22 Hoffmann La Roche anticorpos do receptor de epo anti-humano e métodos de uso
AU2013235741C1 (en) 2012-03-21 2017-12-21 Takeda Pharmaceutical Company Limited TFPI inhibitors and methods of use
CO2018007151A2 (es) 2015-12-11 2018-09-20 Dyax Corp Inhibidores de calicreína plasmática y usos de los mismos para tratar ataque de angioedema hereditario

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
IL87172A (en) * 1987-07-23 1994-12-29 Univ Washington A method of inhibiting the isolation of a purer tissue factor

Also Published As

Publication number Publication date
NO20013608D0 (no) 2001-07-20
JP2002097200A (ja) 2002-04-02
DK413488A (da) 1989-05-24
FI883487A0 (fi) 1988-07-22
JP4025035B2 (ja) 2007-12-19
DE3851511D1 (de) 1994-10-20
DK413488D0 (da) 1988-07-22
JP2005306875A (ja) 2005-11-04
FI883487A (fi) 1989-05-24
JPH1175875A (ja) 1999-03-23
NZ225535A (en) 1990-11-27
EP0318451A2 (en) 1989-05-31
JPH01165383A (ja) 1989-06-29
EP0318451B1 (en) 1994-09-14
NO20013608L (no) 1989-05-24
KR890007750A (ko) 1989-07-05
AU1928788A (en) 1989-05-25
JP3565714B2 (ja) 2004-09-15
NO883270L (no) 1989-05-24
PT88076A (pt) 1988-08-01
JP2836823B2 (ja) 1998-12-14
ES2063769T3 (es) 1995-01-16
IL87171A0 (en) 1988-12-30
CA1341223C (en) 2001-05-01
EP0318451A3 (en) 1990-03-28
FI93365B (fi) 1994-12-15
NO310466B1 (no) 2001-07-09
AU604139B2 (en) 1990-12-06
IE882243L (en) 1989-05-23
KR930000274B1 (ko) 1993-01-14
FI93365C (fi) 1995-03-27
JP2004201696A (ja) 2004-07-22
IL87171A (en) 1995-08-31
ATE111518T1 (de) 1994-09-15
PT88076B (pt) 1993-01-29
DE3851511T2 (de) 1995-03-30
NO883270D0 (no) 1988-07-22
IE65393B1 (en) 1995-10-18

Similar Documents

Publication Publication Date Title
DK173536B1 (da) cDNA-sekvens, som koder for modent humant vævsfaktorinhibitor-protein
US4966852A (en) DNA clone of human tissue factor inhibitor
Wun et al. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.
US7060805B2 (en) Methods for isolating tissue factor inhibitor
Hunt et al. A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alpha1-proteinase inhibitor
Sommer et al. cDNA sequence coding for a rat glia-derived nexin and its homology to members of the serpin superfamily
AU711113B2 (en) Novel serpin derived from human hypothalamus
Zitnik et al. The cloning and characterization of a murine secretory leukocyte protease inhibitor cDNA
US6025143A (en) Antibodies directed against peptides derived from the SMR1 polypeptide
Shen et al. Primary structure of human pancreatic protease E determined by sequence analysis of the cloned mRNA
DK174754B1 (da) Humane vævsfaktorinhibitor (TFI), antistof med bindingsspecificitet herfor, fremgangsmåde til anvendelse af en TFI-peptid-kolonne til at oprense et antistof og fremgangsmåder til detektion af TFI eller et polypeptid omfattende....
DK175431B1 (da) Antistoffer som binder fragmenter af vævsfaktorinhibitor (TFI), sammensætninger omfattende disse antistoffer, og fremgangsmåde til anvendelse af en immunoaffinitetsmatrix omfattende et sådant antistof til at oprense et polypeptid fra et biologisk fluidum
Lai et al. Purification and characterization of a trypsin inhibitor from mouse seminal vesicle secretion
JPH1080281A (ja) 新規蛋白質及びその製造方法
Tejada et al. Cloning of an avian antithrombin: developmental and hormonal regulation of expression
OHLSSON Chemistry and Biology of Secretory Leukoprotease Inhibitor

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK